Alloimmunization in preterm infants after repeated transfusions of WBC-reduced RBCs from the same donor

Area of Science:

• Neonatal Medicine
• Transfusion Medicine
• Immunology

Background:

• Preterm infants are a heavily transfused patient group.
• Alloimmunization against RBC and WBC antigens is rare in multiply transfused infants.
• The impact of limited donor exposure and WBC-reduced RBCs on alloimmunization risk is unknown.

Purpose of the Study:

• To investigate alloimmunization rates in preterm infants exposed to limited donors.
• To assess the potential benefit of WBC-reduced RBC components in preventing alloimmunization.

Main Methods:

• Preterm infants (0.6-1.3 kg birth weight) received prestorage WBC-reduced RBCs from dedicated donors.
• Serial blood samples were collected and tested for RBC and WBC antibodies (HLA class I or neutrophil-specific).

Main Results:

• No infants developed RBC antibodies.
• 13% of infants produced WBC antibodies (excluding passive maternal antibodies).
• WBC antibodies identified were against HLA class I or neutrophil-specific antigens, with no adverse effects.

Conclusions:

• Limited donor exposure programs do not necessitate changes in blood banking practices due to rare RBC antibody production.
• The benefits of WBC reduction are uncertain due to the uncommon occurrence of infant WBC antibody production.
• Further research is required to justify changes in transfusion practices for preterm infants.